IDENTIFICATION OF REVERTANTS FOR THE CYSTIC-FIBROSIS DELTA-F508 MUTATION USING STE6-CFTR CHIMERAS IN YEAST

被引:153
|
作者
TEEM, JL
BERGER, HA
OSTEDGAARD, LS
RICH, DP
TSUI, LC
WELSH, MJ
机构
[1] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
[2] HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA
关键词
D O I
10.1016/0092-8674(93)90233-G
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) cause cystic fibrosis; the most common mutation is deletion of phenylalanine at position 508 (DELTAF508). We constructed STE6-CFTR chimeras with portions of the first nucleotide-binding domain (NBD1) of the yeast STE6 a-factor transporter replaced by portions of CFTR NBD1. The chimeras were functional in yeast, but mating efficiency decreased when DELTAF508 was introduced into NBD1. We isolated two DELTAF508 revertant mutations (R553M and R553Q) that restored mating; both were located within the CFTR NBD1 sequence. Introduction of these revertant mutations into human CFTR partially corrected the processing and Cl- channel gating defects caused by the DELTAF508 mutation. These results suggest that the NBD1s of CFTR and STE6 share a similar structure and function and that, in CFTR, the regions containing F508 and R553 interact. They also indicate that the abnormal conformation produced by DELTAF508 can be partially corrected by additional alterations in the protein.
引用
收藏
页码:335 / 346
页数:12
相关论文
共 50 条
  • [21] CYSTIC-FIBROSIS MUTATION DELTA-F508 IN FINLAND - OTHER MUTATIONS PREDOMINATE
    KERE, J
    SAVILAHTI, E
    NORIO, R
    ESTIVILL, X
    DELACHAPELLE, A
    HUMAN GENETICS, 1990, 85 (04) : 413 - 415
  • [22] SEVERITY OF CYSTIC-FIBROSIS IN PATIENTS HOMOZYGOUS AND HETEROZYGOUS FOR DELTA-F508 MUTATION
    JOHANSEN, HK
    NIR, M
    HOIBY, N
    KOCH, C
    SCHWARTZ, M
    LANCET, 1991, 337 (8742): : 631 - 634
  • [23] DISTRIBUTION OF THE DELTA-F508 MUTATION IN 194 SPANISH CYSTIC-FIBROSIS FAMILIES
    CHILLON, M
    NUNES, V
    CASALS, T
    GIMENEZ, FJ
    FERNANDEZ, E
    BENITEZ, J
    ESTIVILL, X
    HUMAN GENETICS, 1990, 85 (04) : 396 - 397
  • [24] AN IMMORTALIZED CYSTIC-FIBROSIS TRACHEAL EPITHELIAL-CELL LINE HOMOZYGOUS FOR THE DELTA-F508 CFTR MUTATION
    KUNZELMANN, K
    SCHWIEBERT, EM
    ZEITLIN, PL
    KUO, WL
    STANTON, BA
    GRUENERT, DC
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 8 (05) : 522 - 529
  • [25] PROTECTION AGAINST BRONCHIAL-ASTHMA BY CFTR DELTA-F508 MUTATION - A HETEROZYGOTE ADVANTAGE IN CYSTIC-FIBROSIS
    SCHROEDER, SA
    GAUGHAN, DM
    SWIFT, M
    NATURE MEDICINE, 1995, 1 (07) : 703 - 705
  • [26] ENDOCRINE AND EXOCRINE PANCREATIC FUNCTION AND THE DELTA-F508 MUTATION IN CYSTIC-FIBROSIS
    LANNG, S
    SCHWARTZ, M
    THORSTEINSSON, B
    KOCH, C
    CLINICAL GENETICS, 1991, 40 (05) : 345 - 348
  • [27] DNA DIAGNOSIS OF CYSTIC-FIBROSIS BY DIRECT DETECTION OF THE DELTA-F508 MUTATION
    HENDRICKX, J
    WAUTERS, J
    COUCKE, P
    VITS, L
    VANDERAUWERA, B
    WILLEMS, PJ
    ACTA CLINICA BELGICA, 1991, 46 (01): : 13 - 17
  • [28] THE HAPLOTYPE DISTRIBUTION OF THE DELTA-F508 MUTATION IN CYSTIC-FIBROSIS FAMILIES IN SCOTLAND
    MCINTOSH, I
    CURTIS, A
    LORENZO, ML
    KESTON, M
    GILFILLAN, AJ
    MORRIS, G
    BROCK, DJH
    HUMAN GENETICS, 1990, 85 (04) : 419 - 420
  • [29] PRENATAL SCREENING FOR DELTA-F508 MUTATION IN POPULATION NOT SELECTED FOR CYSTIC-FIBROSIS
    BICK, D
    BLACK, SH
    CUMMINGS, E
    COSTAKOS, D
    MADDALENA, A
    HEADRICK, EG
    JONES, SL
    BECKER, R
    SCHULMAN, JD
    LANCET, 1990, 336 (8726): : 1324 - 1325
  • [30] PRENATAL PREDICTION OF CYSTIC-FIBROSIS IN A MOTHER HOMOZYGOUS FOR THE DELTA-F508 MUTATION
    DAHL, N
    KOLLBERG, H
    CLINICAL GENETICS, 1992, 42 (04) : 214 - 215